AnalystsInsight

Michael Zaremski (BMO Capital): Analyst Track Record and Price‑Target Accuracy

How often Michael Zaremski’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 1,226 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • Michael Zaremski ranks #973 of 1,121 analysts in Exent’s scoring (4.6★).
  • 70.0% of price targets were reached over 7 years, versus 53.6% for the average analyst.
  • Median time to reach a target: 105 days; 74.2% of calls were up 12 months later.
  • Most‑covered stocks: PGR, ALL, BRO, KNSL.
  • Free on Exent: Michael Zaremski’s full record, with ratings 3 days after publication.

Michael Zaremski’s track record at a glance

Michael Zaremski of BMO Capital ranks #973 of the 1,121 analysts Exent scores, with a 4.6★ rating and a focus on financials. Over a 7‑year lookback, 70.0% of Michael’s price targets were reached, 16.4 points above the 53.6% average across all analysts.

MetricMichael ZaremskiAll analysts
Price‑target hit rate70.0%53.6%
Median days to hit target105 days91 days
Calls up after 12 months74.2%64.6%
Median 12‑month return of calls+16.9%+13.4%
Hit rate, last 2 years58.9%—
Average worst drop after a call−13.2%—
Ratings in the sample1,226—
Stocks covered47—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetMichael Zaremski
Under 30 days20.6%
30–90 days23.8%
90–180 days27.1%
Over 180 days28.5%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Michael Zaremski covers most

StockRatings in the sample
PGR65
ALL27
BRO23
KNSL20
TRV19
ARX16
MRSH15
AJG14

In the past year Michael’s ratings were 25% Buy, 72% Hold and 3% Sell.

Michael Zaremski’s latest ratings

DateStockActionRatingPrice target
Oct 20, 2026
Oct 15, 2026PGRMaintained: HoldHold$216.00
Oct 15, 2026PGRReiterated: HoldHold$216.00
Oct 14, 2026GSHDReiterated: HoldHold$47.00
Oct 2, 2026THGMaintained: HoldHold$229.00
Oct 1, 2026THGReiterated: HoldHold$229.00
Sep 23, 2026TRVRated: HoldHold$379.00
Sep 18, 2026PGRReiterated: HoldHold$221.00
Sep 15, 2026THGReiterated: HoldHold$225.00
Sep 9, 2026WTWReiterated: BuyBuy$365.00
Aug 31, 2026AONRated: HoldHold$360.00
Aug 25, 2026MRSHReiterated: HoldHold$203.00
Aug 19, 2026PGRReiterated: HoldHold$205.00
  • Oct 20, 2026
    Stock
    Action
    Rating
    Price target
  • Oct 15, 2026
    Stock
    PGR
    Action
    Maintained: Hold
    Rating
    Hold
    Price target
    $216.00
  • Oct 15, 2026
    Stock
    PGR
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $216.00
  • Oct 14, 2026
    Stock
    GSHD
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $47.00
  • Oct 2, 2026
    Stock
    THG
    Action
    Maintained: Hold
    Rating
    Hold
    Price target
    $229.00
  • Oct 1, 2026
    Stock
    THG
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $229.00
  • Sep 23, 2026
    Stock
    TRV
    Action
    Rated: Hold
    Rating
    Hold
    Price target
    $379.00
  • Sep 18, 2026
    Stock
    PGR
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $221.00
  • Sep 15, 2026
    Stock
    THG
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $225.00
  • Sep 9, 2026
    Stock
    WTW
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $365.00
  • Aug 31, 2026
    Stock
    AON
    Action
    Rated: Hold
    Rating
    Hold
    Price target
    $360.00
  • Aug 25, 2026
    Stock
    MRSH
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $203.00
  • Aug 19, 2026
    Stock
    PGR
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $205.00

Michael published 1 rating in the last 3 days, the latest on Oct 20, 2026. Michael’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Oct 20, 2026; ranking updated Oct 21, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Michael Zaremski’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Michael Zaremski ranks #973 of 1,121 with a 4.6★ rating. 70.0% of price targets were reached over a 7-year lookback (all analysts: 53.6%), and 74.2% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Michael Zaremski’s success rate is 67.0% by the ranking source and 70.0% by Exent’s price-target hit-rate backtest, with a median of 105 days to reach a target.

Michael Zaremski (BMO Capital) covers 47 stocks, mostly in financials. The most frequently rated are PGR, ALL, BRO, KNSL, TRV.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.